AI assistant
Sending…
Rapport Therapeutics, Inc. — Director's Dealing 2024
Jun 11, 2024
32034_dirs_2024-06-10_60e33b90-0585-4d14-8f9e-5cfced0a3351.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Rapport Therapeutics, Inc. (RAPP)
CIK: 0002012593
Period of Report: 2024-06-06
Reporting Person: Yeleswaram Krishnaswamy (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-06 | Stock Option (Right to Buy) | $17 | A | 84904 | Acquired | 2034-06-05 | Common Stock (84904) | Direct |
Footnotes
F1: 25% of the shares underlying this option shall vest and become exercisable on June 6, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
More from Rapport Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4